Tie-up with US rival Bristol Myers would have marked return to big pharma mergers
For help please visit help.ft.com. We apologise for any inconvenience.
The following information can help our support team to resolve this issue.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger | 0 | 8.62 | 03-08-2026 |
| 2 | AstraZeneca tratta con Bristol Myers Squibb, allo studio una fusione da quasi 400 miliardi di dollari | 0 | 8.38 | 03-08-2026 |
| 3 | AstraZeneca приобретет фармкомпанию Alexion за $39 млрд | 0 | 0 | 12-12-2020 |
| 4 | Британский регулятор одобрил сделку AstraZeneca с фармкомпанией из США Alexion | 0 | 0 | 14-07-2021 |
| 5 | EasyJet agrees to rival £5.7bn takeover bid by US giant Apollo | 0 | 5 | 10-07-2026 |
| 6 | Baker McKenzie Advises Bayer on USD 2.45 billion Acquisition of Perfuse Therapeutics | 0 | 18.33 | 06-05-2026 |
| 7 | Novo Nordisk v Eli Lilly: return of the weight-loss wars | 0 | 5 | 25-09-2025 |
| 8 | SoftBank продаст американской компании Nvidia всю свою долю в британской Arm | 0 | 0 | 14-09-2020 |
| 9 | FT: британский инвестфонд покупает бренды Lipton и Brooke Bond за $5,1 млрд | 0 | 0 | 18-11-2021 |